Welcome to YLOAN.COM
yloan.com » Marketing » Aarkstore Enterprise - Generics League - Market Analysis And Forecasts, 2007-2012, 2017 &2022
Marketing Advertising Branding Careers-Employment Change-Management Customer Service Entrepreneurialism Ethics Marketing-Direct Negotiation Outsourcing PR Presentation Resumes-Cover-Letters Sales Sales-Management Sales-Teleselling Sales-Training Strategic-Planning Team-Building Top7-or-Top10-Tips Workplace-Communication aarkstore corporate advantages development collection global purchasing rapidshare grinding wildfire shipping trading economy wholesale agency florida attorney strategy county consumer bills niche elliptical

Aarkstore Enterprise - Generics League - Market Analysis And Forecasts, 2007-2012, 2017 &2022

Generics League - Market Analysis and Forecasts

, 2007-2012, 2017 &2022

The generic industry is a fast evolving market; with significant lucrative opportunities. The generic market is structurally set to experience high growth potential. That wave is partly driven by cost-containment in several national healthcare sectors and partly by the need for governments to promote the use of generic products over high-priced originator products without compromising quality.

In 2006, the global generics market attained strong revenues of approximately $65bn, up by 12% in comparison with $58bn in 2005. However, during the same period, the Top Ten leading generic suppliers generated total revenues of $27.9bn, up by a growth rate of 34%. The Top Five Companies within that sector experienced significant revenues, with market growth largely driven by significant commercial activities, key Mergers and Acquisition (M&A) and launch of new product in the leading markets.

In light, of the significant number of proprietary branded pharmaceuticals approaching patent expiration in the near-term, visiongain predicts that the generic market is set to experience further market expansion during the forecast period. Visiongain also predicts that by 2023, the Top Ten leading generic suppliers will experience CAGR of 7%. That significant CAGR, will be driven by generic versions of leading blockbuster drugs presently estimated at $100bn, nearing patent expiration during 2008-2012.


Prominently, amongst the products with looming patent expirations are drugs such as:

For more information, please contact :

http://www.aarkstore.com/reports/Generics-League-Market-Analysis-and-Forecasts-2007-2012-2017-2022-33074.html

Contact : minu

Aarkstore Enterprise

Tel : +912227453309

Mobile No: +919272852585

Email : contact@aarkstore.com

Website : http://www.aarkstore.com

Blog: http://blogs.aarkstore.com/

by: aarkstore enterprise
Simple Formula For Calculating ROI in Search Marketing, SEO Aarkstore Enterprise -the Antipsychotics Market Insight & Analysis 2008 Will RSS Kill Email Marketing? Tips on Writing an Effective Social Media Marketing Request For Proposal (RFP) Aarkstore Enterprise -respiratory Market Insight 2008- Market Research Aggregator How to Create a Marketing Syllabus and Become a Marketing Rock Star Affiliate Marketing - The Reality Entrepreneur's Coaching Center - A 6 Step Marketing Plan Aarkstore Enterprise -fixed-mobile Convergence Market Analysis 2008- Market Research Aggregator Aarkstore Enterprise -mobile Search 2008-2013: Profiting From Information And Advertising On The Mo Aarkstore Enterprise -the Antibacterial Drug Market Analysis 2008-2013- Market Research Aggregator Economic Indicators - What The Unemployment Report Means To Stock Market Investors Aarkstore Enterprise - Chinese Pharmaceutical Outlook 2008-2023 - Market Research Aggregator
print
www.yloan.com guest:  register | login | search IP(216.73.216.60) California / Anaheim Processed in 0.017548 second(s), 7 queries , Gzip enabled , discuz 5.5 through PHP 8.3.9 , debug code: 28 , 2050, 66,
Aarkstore Enterprise - Generics League - Market Analysis And Forecasts, 2007-2012, 2017 &2022 Anaheim